type here...

CATEGORIES

Press Release

LATEST

Editors Choice

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life -
Press Release

MITRE-Harris Poll Survey Finds Half of Patients in the US Feel Ignored or Doubted When Seeking Medical Treatment

Medika Life -
Digital Health

First “Global State of Digital Health Report” Tapping into 200 Million Data Points Examines More Than 12,000 Digital Health Ventures Now Available

Medika Life -
Press Release

Cumulus Neuroscience Appoints Digital Health and Pharma Executive Aman Bhatti, MD as Chief Executive Officer

Medika Life -
Anxiety and Depression

U.S. Prepares Launch of a National Three-Digit Number for the Mental Health Crisis Hotline

Medika Life -
Press Release

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Medika Life -
Press Release

Largest Coordinated HIV Testing Event in the Nation on June 27th

Medika Life -
Press Release

Galien Foundation Announces New Prix Galien Award Category, “Incubators, Accelerators and Equity – Foundational Support for Health Innovation”

Medika Life -
For Doctors

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained

Medika Life -
Press Release

Cogitativo Joins the Veterans Health Administration to Address the Deferred Care Challenge Using AI-Enabled Solution

Medika Life -
123...12Page 2 of 12

TRENDING

EDITORS CHOICE

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Medika Life -
joint efforts will form best practices for non-profit health organizations to leverage patient self-reporting with the goal of advancing science, treatment and quality of life.

Trials Validate Cognition Improvement Using PrimeMyBody Hemp Extract

Medika Life -
Clinical brain mapping screenings of former NFL players who suffer from cognitive deficits provide supportive data that PrimeMyBody's FOCUS Mind & Body Hemp Extract improved brain performance for 80 percent of screening participants

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

At-Home Ultrasounds for Pregnant Women Now A Reality

Medika Life -
A handheld tele-ultrasound device that enables pregnant women to perform at-home ultrasound scans, and receive feedback from a physician or sonographer

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories